Bone Biologics Seeks Shareholder Approval for 1-for-2 to 1-for-10 Reverse Split and 4.35M Warrant Shares
BBLG is trading near its 52-week low of $0.58 (1.3% above the low) on light trading volume (0.1× avg).
Summary
Bone Biologics' definitive proxy seeks approval for a reverse stock split (1-for-2 to 1-for-10) and issuance of 4.35M warrant shares to maintain Nasdaq listing and unlock up to $6M in funding.
Key Events · Corporate Governance and Compliance · BBLG
-
Reverse Stock Split Proposed
Shareholders will vote on a reverse split ranging from 1-for-2 to 1-for-10, with the Board having discretion to select the ratio and timing within one year of the September 28, 2026 annual meeting.
-
Nasdaq Listing at Risk
The stock closed at $0.93 on the August 6 record date, below the $1.00 minimum bid requirement. The reverse split is the primary mechanism to regain compliance and avoid delisting.
-
Warrant Share Issuance Approval
Proposal Four seeks approval to issue 4,352,115 shares underlying warrants (4,225,354 Common Warrant Shares plus 126,761 Placement Agent Warrant Shares), exceeding 20% of the 1,810,380 shares outstanding before the July 7 private placement.
-
Up to $6M in Additional Proceeds
If the Common Warrants are exercised for cash, the company would receive up to approximately $6.0 million in gross proceeds. Failure to approve the warrant share issuance would forfeit this potential funding.
Analysis · BBLG · Industrial Applications And Services
Bone Biologics is asking shareholders to approve a reverse stock split of up to 1-for-10 and the potential issuance of 4.35 million shares underlying warrants from its July private placement. The reverse split is designed to keep the stock above Nasdaq's $1.00 minimum bid requirement — the stock closed at $0.93 on the record date and trades near its 52-week low of $0.58. The warrant share approval unlocks up to $6.0 million in additional proceeds if the warrants are exercised for cash, which the company says is critical to funding operations. Failure to approve either proposal risks Nasdaq delisting and loss of the warrant proceeds.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 35.9% of the 1728 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.06%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BBLG was trading at $0.59 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.7M. The 52-week trading range was $0.58 to $4.13. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.